Clinical features and outcome of HIV/SARS-CoV-2 coinfected patients in The Bronx, New York city.
作者信息
Suwanwongse Kulachanya, Shabarek Nehad
机构信息
Department of Internal Medicine, Lincoln Medical Center, The Bronx, New York.
出版信息
J Med Virol. 2020 Nov;92(11):2387-2389. doi: 10.1002/jmv.26077. Epub 2020 Jun 9.
Abstract
摘要
相似文献
1
Clinical features and outcome of HIV/SARS-CoV-2 coinfected patients in The Bronx, New York city.纽约市布朗克斯区HIV/SARS-CoV-2合并感染患者的临床特征与转归
J Med Virol. 2020 Nov;92(11):2387-2389. doi: 10.1002/jmv.26077. Epub 2020 Jun 9.
2
HIV/SARS-CoV-2 coinfected patients in Istanbul, Turkey.土耳其伊斯坦布尔的HIV/SARS-CoV-2合并感染患者。
J Med Virol. 2020 Nov;92(11):2288-2290. doi: 10.1002/jmv.25955. Epub 2020 Jun 3.
3
The characteristics of two patients coinfected with SARS-CoV-2 and HIV in Wuhan, China.中国武汉两名同时感染新冠病毒和艾滋病毒患者的特征。
J Med Virol. 2021 Jan;93(1):85-88. doi: 10.1002/jmv.26155. Epub 2020 Jun 24.
4
Living with HIV in the time of COVID-19: A glimpse of hope.新冠疫情期间的艾滋病毒感染者：一线希望
J Med Virol. 2021 Jan;93(1):59-60. doi: 10.1002/jmv.26118. Epub 2020 Jun 9.
5
Comments on "coinfection of SARS-CoV-2 and HIV in a patient in Wuhan city, China".关于“中国武汉市一名患者感染新冠病毒和艾滋病毒的合并感染情况”的评论
J Med Virol. 2020 Sep;92(9):1416. doi: 10.1002/jmv.25821. Epub 2020 Apr 8.
6
Variation in mortality of HIV/SARS-CoV-2 coinfected patients in the Bronx, New York City.纽约市布朗克斯区HIV/SARS-CoV-2合并感染患者的死亡率差异。
J Med Virol. 2021 Feb;93(2):603-605. doi: 10.1002/jmv.26370. Epub 2020 Aug 13.
7
The Unpredictable Outcome of SARS-CoV-2 in Kidney Transplant Recipients With HIV-infection.感染HIV的肾移植受者中SARS-CoV-2的不可预测结果
Transplantation. 2021 Jan 1;105(1):e9-e10. doi: 10.1097/TP.0000000000003529.
8
The first 6 months of HIV-SARS-CoV-2 coinfection: outcomes for 6947 individuals.HIV与SARS-CoV-2合并感染的前6个月：6947例个体的结局
Curr Opin HIV AIDS. 2021 Jan;16(1):54-62. doi: 10.1097/COH.0000000000000654.
9
COVID-19 and Tuberculosis Coinfection in a 51-Year-Old Taxi Driver in Mexico City.墨西哥城一名51岁出租车司机的新冠病毒与结核病合并感染情况
Am J Case Rep. 2020 Nov 5;21:e927628. doi: 10.12659/AJCR.927628.
10
Clinical outcomes and features of COVID-19 in patients with primary immunodeficiencies in New York City.纽约市原发性免疫缺陷患者中 COVID-19 的临床结局和特征。
J Allergy Clin Immunol Pract. 2021 Jan;9(1):490-493.e2. doi: 10.1016/j.jaip.2020.09.052. Epub 2020 Oct 8.
引用本文的文献
1
A questionnaire-based survey on the epidemiological and clinical characteristics of SARS-CoV-2 infection in patients with chronic HBV infection and HIV infection.一项基于问卷调查的关于慢性乙型肝炎病毒感染和艾滋病毒感染患者中新型冠状病毒感染的流行病学和临床特征的调查。
Front Public Health. 2025 Mar 13;13:1536794. doi: 10.3389/fpubh.2025.1536794. eCollection 2025.
2
Difference of SARS-CoV-2 infection and influence factors between people with and without HIV infection.新型冠状病毒感染在HIV感染者与非HIV感染者之间的差异及影响因素
BMC Public Health. 2025 Jan 30;25(1):386. doi: 10.1186/s12889-025-21400-8.
3
Impact of COVID-19 on Utilization of Healthcare Services Among People Living with HIV (PLHIV): A Systematic Review.2019冠状病毒病对艾滋病毒感染者医疗服务利用情况的影响：一项系统评价
Medicina (Kaunas). 2025 Jan 14;61(1):111. doi: 10.3390/medicina61010111.
4
Factors affecting poor prognosis of COVID-19 in people living with human immunodeficiency virus: A systematic review and meta-analysis of co-infection.影响人类免疫缺陷病毒感染者中COVID-19预后不良的因素：合并感染的系统评价和荟萃分析
Int J Health Sci (Qassim). 2025 Jan-Feb;19(1):49-55.
5
Viral Load Suppression in People Living with HIV Before and During the COVID-19 Pandemic in Brooklyn, New York.在纽约布鲁克林，HIV 感染者在新冠疫情之前和期间的病毒载量抑制情况。
AIDS Behav. 2024 Sep;28(9):2961-2969. doi: 10.1007/s10461-024-04385-0. Epub 2024 Jun 5.
6
Clinical outcomes and immunological response to SARS-CoV-2 infection among people living with HIV.HIV 感染者感染 SARS-CoV-2 的临床结局和免疫反应。
Exp Biol Med (Maywood). 2024 Apr 2;249:10059. doi: 10.3389/ebm.2024.10059. eCollection 2024.
7
Identifying Markers of Emerging SARS-CoV-2 Variants in Patients With Secondary Immunodeficiency.识别继发性免疫缺陷患者中新兴的严重急性呼吸综合征冠状病毒2（SARS-CoV-2）变体的标志物。
Front Microbiol. 2022 Jul 1;13:933983. doi: 10.3389/fmicb.2022.933983. eCollection 2022.
8
Assessing the impact of SARS-CoV-2 infection on the dynamics of dengue and HIV via fractional derivatives.通过分数阶导数评估严重急性呼吸综合征冠状病毒2（SARS-CoV-2）感染对登革热和艾滋病病毒动态的影响。
Chaos Solitons Fractals. 2022 Sep;162:112427. doi: 10.1016/j.chaos.2022.112427. Epub 2022 Jul 11.
9
HIV epidemic amidst COVID-19 pandemic in India: a conundrum for the country's healthcare system.印度 COVID-19 大流行期间的 HIV 疫情：对该国医疗体系的难题。
Epidemiol Infect. 2022 May 26;150:e112. doi: 10.1017/S095026882200098X.
10
SARS-CoV-2 and HIV co-infection; clinical features, diagnosis, and treatment strategies: A systematic review and meta-analysis.严重急性呼吸综合征冠状病毒2型（SARS-CoV-2）与人类免疫缺陷病毒（HIV）合并感染：临床特征、诊断及治疗策略：一项系统综述与荟萃分析
Gene Rep. 2022 Jun;27:101624. doi: 10.1016/j.genrep.2022.101624. Epub 2022 May 19.
本文引用的文献
1
Benign course of COVID-19 in a multiple sclerosis patient treated with Ocrelizumab.使用奥瑞珠单抗治疗的多发性硬化症患者中COVID-19的良性病程。
Mult Scler Relat Disord. 2020 Jul;42:102201. doi: 10.1016/j.msard.2020.102201. Epub 2020 May 15.
2
COVID-19 in people living with human immunodeficiency virus: a case series of 33 patients.COVID-19 合并人类免疫缺陷病毒感染患者：33 例病例系列研究。
Infection. 2020 Oct;48(5):681-686. doi: 10.1007/s15010-020-01438-z. Epub 2020 May 11.
3
HIV/SARS-CoV-2 coinfected patients in Istanbul, Turkey.土耳其伊斯坦布尔的HIV/SARS-CoV-2合并感染患者。
J Med Virol. 2020 Nov;92(11):2288-2290. doi: 10.1002/jmv.25955. Epub 2020 Jun 3.
4
COVID-19 in a MS patient treated with ocrelizumab: does immunosuppression have a protective role?奥瑞珠单抗治疗多发性硬化症患者合并 COVID-19：免疫抑制是否具有保护作用？
Mult Scler Relat Disord. 2020 Jul;42:102120. doi: 10.1016/j.msard.2020.102120. Epub 2020 Apr 15.
5
COVID-19 in patients with HIV: clinical case series.艾滋病毒感染者中的新型冠状病毒肺炎：临床病例系列
Lancet HIV. 2020 May;7(5):e314-e316. doi: 10.1016/S2352-3018(20)30111-9. Epub 2020 Apr 15.
6
Could HIV infection alter the clinical course of SARS-CoV-2 infection? When less is better.HIV感染会改变SARS-CoV-2感染的临床病程吗？越少越好。
J Med Virol. 2020 Oct;92(10):1777-1778. doi: 10.1002/jmv.25881. Epub 2020 Jul 11.
7
Clinical characteristics of coronavirus disease 2019 (COVID-19) in China: A systematic review and meta-analysis.《中国 2019 年冠状病毒病（COVID-19）的临床特征：系统评价和荟萃分析》
J Infect. 2020 Jun;80(6):656-665. doi: 10.1016/j.jinf.2020.03.041. Epub 2020 Apr 10.
8
Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study.中国武汉成人 COVID-19 住院患者的临床病程和死亡危险因素：一项回顾性队列研究。
Lancet. 2020 Mar 28;395(10229):1054-1062. doi: 10.1016/S0140-6736(20)30566-3. Epub 2020 Mar 11.
9
Risk Factors Associated With Acute Respiratory Distress Syndrome and Death in Patients With Coronavirus Disease 2019 Pneumonia in Wuhan, China.中国武汉 2019 年冠状病毒病肺炎患者急性呼吸窘迫综合征和死亡的相关危险因素。
JAMA Intern Med. 2020 Jul 1;180(7):934-943. doi: 10.1001/jamainternmed.2020.0994.
Zotero 插件